What are the implications of administering a medication at a rate of 1 milligram (mg) per minute for one hour?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amiodarone Maintenance Infusion at 1 mg/min for One Hour

Administering amiodarone at 1 mg/min for one hour delivers 60 mg total and represents the standard maintenance infusion rate used after initial loading doses for life-threatening ventricular arrhythmias. 1, 2

Standard Dosing Protocol

The American Heart Association guidelines establish that after initial loading (150 mg over 10 minutes), amiodarone should be infused at 1 mg/min for 6 hours as part of the first 24-hour regimen, followed by 0.5 mg/min thereafter. 1 Therefore, a 1 mg/min rate for one hour is:

  • Part of the standard 6-hour maintenance phase following the loading dose 2
  • Delivers 60 mg over that hour (1 mg × 60 minutes)
  • Contributes to the recommended ~1000 mg total dose over the first 24 hours 2

Clinical Context and Indications

This infusion rate is appropriate for:

  • Hemodynamically stable monomorphic ventricular tachycardia 1
  • Polymorphic VT with normal QT interval 1
  • Stable irregular narrow complex tachycardia (atrial fibrillation) 1
  • Control of rapid ventricular rate in pre-excited atrial arrhythmias 1

Critical Safety Considerations

Administration Requirements

Amiodarone MUST be delivered by volumetric infusion pump—never use drop counter sets, as they can underdose by up to 30%. 2 Additional requirements include:

  • Use central venous catheter whenever possible for concentrations >2 mg/mL 2
  • Administer through dedicated IV line with in-line filter 2
  • Use glass or polyolefin bottles (not evacuated glass containers) for infusions >2 hours 2
  • Prepare in D5W only—amiodarone forms precipitates with multiple other solutions 2

Concentration Limits

For peripheral venous access during this 1 mg/min infusion:

  • Do not exceed 2 mg/mL concentration to minimize phlebitis risk 2
  • Concentrations >3 mg/mL cause high incidence of peripheral vein phlebitis 2
  • Central line required for concentrations >2 mg/mL 2

Monitoring for Adverse Effects

The primary risks during this maintenance infusion include:

  • Hypotension (most common reason for discontinuation)—slow infusion rate and add vasopressors/volume as needed 1, 2
  • Bradycardia—slow or discontinue infusion 1, 2
  • Phlebitis at peripheral sites 1

Maximum Duration

Maintenance infusion up to 0.5 mg/min can be continued for 2-3 weeks regardless of age, renal function, or left ventricular function, though experience beyond 3 weeks is limited. 2 The rate may be increased from 0.5 mg/min to achieve arrhythmia suppression, but total 24-hour dose should not exceed 2.2 g (mean daily doses >2100 mg increase hypotension risk). 1, 2

Breakthrough Arrhythmias

If VF or hemodynamically unstable VT recurs during the 1 mg/min maintenance infusion, administer supplemental 150 mg bolus (in 100 mL D5W over 10 minutes). 1, 2

Transition to Oral Therapy

When switching from IV to oral amiodarone after this infusion phase, the oral dose depends on duration of IV therapy. 2 For example, after <1 week of IV therapy at 0.5-1 mg/min, initiate oral amiodarone at 800-1600 mg daily. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.